TB-500
Synthetic fragment of thymosin β-4. Promoted for tissue repair and inflammation. WADA-prohibited in sport.
At a glance
- Common vial size
- 5 mg
- Reference dose
- 2.5 mg
- Frequency
- 1–2× weekly
Reference titration protocol
Flat 2.5 mg, no escalation, twice weekly.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 2.5 mg | 4 weeks | 2× |
A 5 mg vial reconstituted with 2 mL of bacteriostatic water yields 2.5 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorClinical notes
- WADA S2 — prohibited at all times for athletes
Available formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- Injectable503A
- Lyophilized PowderRUO
- Pen503B
References
Often used with
Compounds commonly discussed alongside TB-500 in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
